<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:department>Comparative Biomedical Sciences CBS</gtr:department><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B55E7FBB-A4A2-4EA2-926B-D9856F43B5AD"><gtr:id>B55E7FBB-A4A2-4EA2-926B-D9856F43B5AD</gtr:id><gtr:firstName>Michelangelo</gtr:firstName><gtr:surname>Campanella</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FN007042%2F1"><gtr:id>B7380467-5AE2-449E-913A-C98C5840D751</gtr:id><gtr:title>The Resilient Brain. Imaging Biomarkers of Brain Metabolic Reserve</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/N007042/1</gtr:grantReference><gtr:abstractText>This proposal aims to validate two innovative biomarkers of brain resilience to ageing. The biomarkers use two well-known and widely available imaging technologies, magnetic resonance imaging (MRI) and positron emission tomography (PET) that are presently used both in animals and humans. 
The quest for biomarkers of ageing is a difficult one as their necessary requirement is prediction power - ideally, when studying an intervention aimed at modulating the ageing process, we would like to know its effect on the ageing trajectory as soon as possible without having to wait for the ageing process to eventually happen. In the case of brain, this can be achieved if we can measure its resilience - and the one relevant biological parameter determining the ability to withhold cellular pathology is its metabolic reserve.
Why metabolism? In the average adult human, the brain represents about 2% of the total body weight yet it accounts for 20% of all the energy consumed, 10 times that predicted by its weight alone. Note that this very high rate of energy consumption is required only by its resting state while the additional energy associated with any mental activity is remarkably small, often less than 5% of the baseline.
In this highly energetic organ, metabolic reserve is the amount of energy reserve that brain cells can still use to fight all those pathological phenomena that we call ageing. Big metabolic reserve will then mean great resilience to ageing, poor or no reserve means little or no resilience.
When measuring energy reserve we wish to target the functioning of small cellular organelles called mitochondria. There are two key observations about mitochondria. 
1)They are the fundamental elements of the cellular machine performing aerobic respiration e.g. using oxygen to oxidise the products of glucose and convert them into energy. 
2) The process of mitochondria maintenance is highly dynamic with a constant turnover of these components particularly the older and damaged ones.
We have focused on these two key aspects of mitochondrial function and devised two measures.
1) MEASURE 1 - We wish to measure mitochondrial respiratory reserve capacity by measuring oxygen cellular metabolism with MRI before and after a challenge with Methylene Blue (MB). MB is a compound, already authorized for human use, that induces substantial increases (&amp;gt;40%) in cell respiration. Using MB we can expand mitochondrial capacity to its limit, far more than using any mental task that requires very little incremental energy and is far less controllable in an experimental or clinical setting. 
2) MEASURE 2 - We wish to measure the level of expression of one particular mitochondrial protein, called the 18Kd translocator protein or TSPO. TSPO regulates mitochondrial turnover and acts as a quality controller driving the process that removes defective mitochondria following damage or stress. Importantly TSPO levels can be measured in-vivo by PET in both animals and humans. 
We will validate these measures by following through time two groups of rats. One group of rats will be submitted to an intervention which is known to benefit the brain ageing process and mitochondria function in particular. The treatment will consist in environmental enrichment and dietary restriction by which we will mimic human healthy lifestyle. During their lifetime, we will continuously monitor their cognitive ability using appropriate tests and we will verify whether our measures, taken early on, predict their mental decline. 
Once validated, these measures will be extremely powerful tools for ageing research. They will shorten timings in experimental settings and will allow an optimal use of animals as they do not require animal sacrifice. They will be immediately translated to humans as both imaging technologies and the pharmacological challenge used have been separately validated and authorized for human use.</gtr:abstractText><gtr:technicalSummary>The great challenge of ageing research stays in its inherent time-scale where the ideal biomarkers are those that can qualify treatments at baseline without having to wait for the degenerative process to take place. Here we are concerned with brain ageing and focusing on metabolism as the brain has, by far, the highest energy demands of any organ based on its size. Importantly, the brain works at the border of its energy envelope as the majority of this energy is used to support neuronal activity and functional processes and is little affected by task performance. The metabolic reserve theory indeed proposes that a brain that is metabolic efficient is more resilient to declining cognition. It is now established that lifestyle determinants of metabolic reserve promote neuroprotection by increasing brain metabolic efficiency and creating an energetic buffer that can be used by the cell to fight pathology. 
Mitochondria are fundamental to the maintenance of cellular health but with age they lose capacity for efficient ATP generation. Damaged mitochondria are generally cleared by mitophagy and protects from ageing-associated degeneration. This leads us to propose two in-vivo measures of brain metabolic reserve:
1) Cerebral Oxygen Metabolic Reserve obtained by measuring oxygen metabolism with quantitative BOLD MRI before and after administration of methylene blue (MB), an inducer of metabolic respiration already approved for use in man. The use of MB will allow us to tap into cellular energetic buffers that would not be otherwise accessed by experimental tasks (e.g. sensory stimulation).
2) Density expression of the 18K Translocator Protein (TSPO). TSPO is a mitochondrial protein with a fundamental role in mitochondrial quality control that in man is visualized using Positron Emission Tomography. 
Measures will be validated in a longitudinal setting to determine their potential to predict cognitive resilience in well-characterized models of healthy ageing.</gtr:technicalSummary><gtr:potentialImpactText>This proposal focuses on the validation of two novel measurements of brain metabolic reserve to be used in the study of ageing and neurodegenerative disorders in animal and, in the future, human models. This project, if successful, will have substantial and lasting impact. 
The increasingly large ageing population places great pressure on the HEALTH AND SOCIAL CARE SYSTEMS. Currently 16% of the European population is over 65, with this figure to reach 25% by 2030. Effective and predictive biomarkers are key to develop therapies and products aimed at improving lifelong health and wellbeing. Effective biomarkers will allow INDUSTRIES to effectively accelerate the development of products aimed at the ageing population market and enable REGULATORY AGENCIES to test the anti-ageing treatments that are now flooding the market. These include, for example, some poorly validated interventions such as improving antioxidant status and hormone replacement therapies, including growth hormone, testosterone, dehydroepiandrosterone, and melatonin (Butler et al, Journal of Gerontology: Biological Sciences, 2004, Vol. 59A, No. 6, 560-567). 
It is easy to predict the immediate translation of these methodologies also to the study of neurodegenerative disorders. These are conditions that result in the progressive degeneration or death of nerve cells. They include Alzheimer's disease and other dementias, Parkinson's disease, Huntington's disease, motor neuron disease and multiple sclerosis. In the UK it has been estimated that dementia alone costs the ECONOMY &amp;pound;17 billion pounds a year, hence any effective development in this area will impact not only patients but also CARERS, HEALTH PROFESSIONALS and SOCIETY AT LARGE. 
The methodologies proposed are destined to be used on MRI and PET scanners for animal and human use. If effective, they will expand their number and their use of these existing technologies in research, industry and in the clinic making them more economically viable. Hencethey will have direct impact on MEDICAL DIAGNOSTICS INDUSTRIES (General Electric, Siemens, Phillips, Bruker etc.). 
Importantly, by targeting in-vivo biomarkers of mitochondrial function, we are working in a largely un-explored area of the neurosciences. In the recent past, concerns have existed about the growing number of companies disinvesting from neuroscience research in the UK. This has negatively impacted JOBS in this area and the UK ECONOMY at large. The tide has been turning recently with companies with long heritage in brain research such as Lily, Johnson and Johnson, Lundbeck and GSK supporting innovative programmes such as One Mind for research (1mind4research.org) to create a united effort to advance translational research for mental health between GOVERNMENT, ACADEMIA and INDUSTRY. We are already part of one Wellcome supported consortium that unites the organizations above for a strategic award in the area of dementias and mood disorders, all related to ageing, where the need for effective markers of brain bioenergetics is strongly felt.
Finally, it is worth remarking the unique nature of the proposing team with members working in an original setting that stretches from cellular biology to pharmacology, brain energetics, physics, engineering, nuclear imaging and psychology. The scientists and RAs working in this project will have a unique opportunity to expand their KNOWLEDGE BASE from cell biology to cognition, increasing their SKILL-SET in unprecedented fashion. As academics we will be able to communicate the hopefully successful return of this investment to our student population and to the PUBLIC.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-11-20</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2016-11-21</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>362061</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Cell Biology and Pharmacology Elucidation of Mitophagy Activators</gtr:description><gtr:id>2F6CA959-12DB-4EDD-8BDB-20E8261A9AA0</gtr:id><gtr:impact>One Manuscript published</gtr:impact><gtr:outcomeId>5460bdf3479118.93076549-1</gtr:outcomeId><gtr:partnerContribution>Our work proved instrumental to move forward the development of chemicals synthesised by Geoff Wells and collaborators as well as to consent an actual technological improvement in the field of mitophagy activation/regulation.</gtr:partnerContribution><gtr:piContribution>My team assessed the in cell function of chemicals devised by colleague of the UCL SoP (Dr. Geoff Wells).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>TSPO role in Cancer Cell Biology and Oncogenesis</gtr:description><gtr:id>35851520-93AB-4D87-A368-4C739F88FFDA</gtr:id><gtr:impact>There are two manuscripts finalised to be submitted in the incoming months and another grant application under evaluation.</gtr:impact><gtr:outcomeId>56dd6f2417f3b8.84482800-3</gtr:outcomeId><gtr:partnerContribution>We designed, developed and completed the experimental work and immunohistochemial analysis on TSPO on breast cancer tissues.
An accurate evaluation of the underlying regulatory pathways is currently progressing which should lead to an high impact revaluation of the mitochondria-nucleus signalling.</gtr:partnerContribution><gtr:piContribution>We received extra charity funds to run parallel work on the comparative relevance of TSPO role in cancer biology and oncogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Veterinary College (RVC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>TSPO role in Cancer Cell Biology and Oncogenesis</gtr:description><gtr:id>11A26EBF-D4EE-4356-9FEB-D42CE353A38F</gtr:id><gtr:impact>There are two manuscripts finalised to be submitted in the incoming months and another grant application under evaluation.</gtr:impact><gtr:outcomeId>56dd6f2417f3b8.84482800-1</gtr:outcomeId><gtr:partnerContribution>We designed, developed and completed the experimental work and immunohistochemial analysis on TSPO on breast cancer tissues.
An accurate evaluation of the underlying regulatory pathways is currently progressing which should lead to an high impact revaluation of the mitochondria-nucleus signalling.</gtr:partnerContribution><gtr:piContribution>We received extra charity funds to run parallel work on the comparative relevance of TSPO role in cancer biology and oncogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>TSPO role in Hormonal Chemotherapy Resistance</gtr:description><gtr:id>E3A49D46-7D1A-4198-86C4-EB1A0ACAD797</gtr:id><gtr:impact>Grants is being drafted</gtr:impact><gtr:outcomeId>56e14e837c74e7.94134370-1</gtr:outcomeId><gtr:partnerContribution>The main goal is trap the definition of pro-survival genes transcription mediated by TSPO and its potential intracellular relocation from mitochondrial outer membrane when pathologically overexpressed. 

Concomitantly TSPO ligands are being tested as pharmacological means to facilitate/promote chemotherapy induced cell death and prevent long-term resistance.</gtr:partnerContribution><gtr:piContribution>We are defining the link between cholesterol mediated resistance to hormonal chemotherapy and TSPO triggered expression in mammary cancer models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Veterinary College (RVC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Comparative Biomedical Sciences</gtr:department><gtr:description>TSPO role in Osteoarthritis (OA) and Bone Remodelling</gtr:description><gtr:id>6CB1CFB6-D077-4C4E-9E61-754A9A5D37EC</gtr:id><gtr:impact>We have a drafted manuscript to be soon submitted</gtr:impact><gtr:outcomeId>56e14a572e6264.91840122-1</gtr:outcomeId><gtr:partnerContribution>Our contribution consisted in defining the pattern of expression and role in mitochondrial morphology and quality control mediation.</gtr:partnerContribution><gtr:piContribution>We are dissecting the contribution by TSPO in Osteoarthritis (OA) and mediated bone pathology. We are doing so in respect of the role played by TSPO in general and targeted autophagy (mitophagy).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brain Bank</gtr:department><gtr:description>Testing of the antipsychotic drugs on TSPO</gtr:description><gtr:id>9D456C3B-BFC6-4370-A132-B5F562FE3D8A</gtr:id><gtr:impact>Clarification of TSPO role in trafficking neuro specific drugs, affecting their performance and outcome.</gtr:impact><gtr:outcomeId>58c7f081202737.43089037-1</gtr:outcomeId><gtr:partnerContribution>Expertise in clinical pharmacology, sharing of reagents.</gtr:partnerContribution><gtr:piContribution>Research Group of Dr. Anthony Vernon (King's College London Institute of Psychiatric)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brain Bank</gtr:department><gtr:description>Elucidate the Neuronal Cell Biology of the Neuroimaging Tool TSPO</gtr:description><gtr:id>67165B15-E4A6-43AA-A2E1-9DCB69FB0FA9</gtr:id><gtr:impact>A manuscript is now submitted for final revision which will outline TSPO role in neurotoxicity besides characterising its function in cell signalling homeostasis.</gtr:impact><gtr:outcomeId>545bc6bb5cd7d2.86354672-1</gtr:outcomeId><gtr:partnerContribution>Research Grant Share to support a PDRA and consumable.</gtr:partnerContribution><gtr:piContribution>Coordination of the research work on functional role of the PET tracer TSPO in neuronal cell physiology and toxicity determination.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Padova</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>TSPO role in Cancer Cell Biology and Oncogenesis</gtr:description><gtr:id>4D2FD4CD-F687-4D01-A47D-9B7A6E32437A</gtr:id><gtr:impact>There are two manuscripts finalised to be submitted in the incoming months and another grant application under evaluation.</gtr:impact><gtr:outcomeId>56dd6f2417f3b8.84482800-2</gtr:outcomeId><gtr:partnerContribution>We designed, developed and completed the experimental work and immunohistochemial analysis on TSPO on breast cancer tissues.
An accurate evaluation of the underlying regulatory pathways is currently progressing which should lead to an high impact revaluation of the mitochondria-nucleus signalling.</gtr:partnerContribution><gtr:piContribution>We received extra charity funds to run parallel work on the comparative relevance of TSPO role in cancer biology and oncogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC London Interdisciplinary Biosciences PhD Consortium</gtr:description><gtr:end>2020-10-02</gtr:end><gtr:fundingOrg>Bloomsbury Colleges</gtr:fundingOrg><gtr:fundingRef>Flirting In The Little Space: Homeostatic Regulation of The Mitochondria and Cytoskeleton Interplay via The Tubulin-?Vdac-?Tspo Pathway</gtr:fundingRef><gtr:id>47E7922D-CF61-40C4-9F15-EFF9B36974DA</gtr:id><gtr:outcomeId>58c7e011c55976.16395460</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC iCase Studentship</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Bioactive targets of mitochondrial quality control and function.</gtr:fundingRef><gtr:id>A25B0F8D-E074-4D03-B245-681DCF6663B1</gtr:id><gtr:outcomeId>56ded5437da970.73328209</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC-LiDo Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Imaging the Ageing Brain: Cellular and PET Tracing of the Neuroinflammatory Protein TSPO</gtr:fundingRef><gtr:id>47AE334C-DE76-4557-BE4C-C1AB8E1AE624</gtr:id><gtr:outcomeId>545bb9d5b75027.93682858</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>87000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Petplan Charitable Trust</gtr:fundingOrg><gtr:fundingRef>Chemo-targeting of TSPO to validate Endocrine Therapy in Canine Mammary Tumours</gtr:fundingRef><gtr:id>A78883F7-B0DF-4112-A264-7448F8389844</gtr:id><gtr:outcomeId>58c7e0ec9eca36.28465985</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/N007042/1</gtr:fundingRef><gtr:id>E1729181-9898-4CDC-9AE5-F98924B7B419</gtr:id><gtr:outcomeId>56ded5e22ec349.86821755</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC-iCase Studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Focusing on the mitochondrial expression of TSPO as a marker and promoter of neuroinflammation</gtr:fundingRef><gtr:id>804889EF-AA22-45B3-843D-E3E91E81ADB5</gtr:id><gtr:outcomeId>56ded4e94f9e03.73888561</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The major findings from the work developed till now regard the parallel between mitochondrial import of cholesterol and oxysterols which are involved in neurodegenerative phenotypes.</gtr:description><gtr:exploitationPathways>These are likely to deliver both an academic and applicative outcome.</gtr:exploitationPathways><gtr:id>945D125C-454E-420E-843C-E5B614BA4F0D</gtr:id><gtr:outcomeId>58c8072eaaab41.49463889</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>3i Case Panel Memmbership BBSRC London Interdisciplinary Biosciences PhD Consortium</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>5929F578-6F92-4D95-B42B-9742129B4567</gtr:id><gtr:outcomeId>58c7dc58a07d51.65761360</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We are devising a way via which we can score tumor stages in animals by checking TSPO expression</gtr:description><gtr:id>903C1678-D3BB-4513-8507-85B98FA2CCD0</gtr:id><gtr:impact>A potential way to image diagnostically tumor stage and progression via TSPO</gtr:impact><gtr:outcomeId>56e15404639555.10911951</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cancer Biomarker</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A new tool to physiologically activate mitophagy which we called PMI as working via the p62 pathway.</gtr:description><gtr:id>C5C3F0FE-6241-4B93-B518-138FB5AF81CE</gtr:id><gtr:impact>Mitochondrial quality control is a fundamental process in cellular homeostasis, and its deficiency is linked to several
neurodegenerative diseases and cancers. Despite this, the discrete mechanisms, regulatory pathways, and impact oncellular physiology are still far from being elucidated. The current canonical methods to trigger mitophagy in vitro typically involve the abrupt depolarization of mitochondrial membrane potential (DYm) using ionophores such as carbonyl cyanide m-chlorophenyl hydraz</gtr:impact><gtr:outcomeId>5457ad55a61b98.44512302</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mitophagy Inducer</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>961D8AC9-3F1C-4563-8483-999F0A297FA4</gtr:id><gtr:title>Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e2b35510da18c4d24ede0199ba63a6c"><gtr:id>4e2b35510da18c4d24ede0199ba63a6c</gtr:id><gtr:otherNames>Liao C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7d29271a257.14067985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>764E6C09-A5E7-4CF5-A658-C560BC14F9A8</gtr:id><gtr:title>Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1&amp;nbsp;Unveils a Pro-survival Relay via OPA1.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432a93a0abc1c455d7acbe3bdeeae1de"><gtr:id>432a93a0abc1c455d7acbe3bdeeae1de</gtr:id><gtr:otherNames>Faccenda D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c7d2924093d3.61639629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1961CA6-0CBB-468B-922E-E8B7BA0EED09</gtr:id><gtr:title>The pharmacological regulation of cellular mitophagy.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c08cb81b6116354ab8be45d9db46c2d"><gtr:id>9c08cb81b6116354ab8be45d9db46c2d</gtr:id><gtr:otherNames>Georgakopoulos ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>58c7dd12a5f154.51959925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F37B259-58AF-44F7-AD23-9825536F80B9</gtr:id><gtr:title>Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c08cb81b6116354ab8be45d9db46c2d"><gtr:id>9c08cb81b6116354ab8be45d9db46c2d</gtr:id><gtr:otherNames>Georgakopoulos ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a35ae1270d670.92294160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20F54FD1-AA2F-4164-B9DA-2891EC405EAE</gtr:id><gtr:title>Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/985daa6c682db24b1c2b0b9d0de8b00b"><gtr:id>985daa6c682db24b1c2b0b9d0de8b00b</gtr:id><gtr:otherNames>Hawkins KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>58c7d292aee500.95549651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C80AA54-5331-4015-99C0-A12601FAF067</gtr:id><gtr:title>Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis.</gtr:title><gtr:parentPublicationTitle>Seminars in ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cec6c84a2afcce86e868e7c8577efd72"><gtr:id>cec6c84a2afcce86e868e7c8577efd72</gtr:id><gtr:otherNames>D'Ambrosio EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0882-0538</gtr:issn><gtr:outcomeId>5aa7af60a33252.14015075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>839A1232-DEC5-406C-90AF-EE8C00217B28</gtr:id><gtr:title>Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e476d3674e292a046edc7669c4a8396f"><gtr:id>e476d3674e292a046edc7669c4a8396f</gtr:id><gtr:otherNames>Beffagna G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c7d292dd5fc1.88113620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3913B936-3451-4673-8EA4-9C738842C687</gtr:id><gtr:title>Molecular Biology Digest of Cell Mitophagy.</gtr:title><gtr:parentPublicationTitle>International review of cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c967aeac745ed9d23adaeac49e92894"><gtr:id>0c967aeac745ed9d23adaeac49e92894</gtr:id><gtr:otherNames>Matic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1937-6448</gtr:issn><gtr:outcomeId>5aa7af60640a28.03012727</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/N007042/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>E793F7FE-614C-4A45-83A0-BE79B172092C</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal &amp; human physiology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>21792584-97FF-4E36-9A3A-B992BE1DF6A4</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioenergetics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F439A20B-A9B0-4A68-B703-7F6AE7570E39</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Systems neuroscience</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>